STAA · XBRL financial data

STAAR Surgical financial statements, every quarter

The same tables from 12 filings, lined up. Matched by XBRL tag: renamed lines keep their history.

How these numbers work

Every number comes from the company's XBRL financial data filed with the SEC, and each one links to its filing.
Lines are matched by XBRL tag, so a line renamed between filings keeps its history.
* marks a quarter worked out from the filing totals: the 10-K year minus the first three quarters, or a year-to-date total minus the earlier one. Fourth-quarter earnings per share is fourth-quarter net income over the fourth-quarter weighted shares.
0 means a filing states zero; a dash (—) means no filing states that number.
“year only” means the 10-K gives the full year but not the quarters needed to work out the fourth. A worked-out quarter of revenue, cost of revenue or operating cash flow more than twice the company's largest quarter of the two years before is shown this way too.
Gross profit is shown as the company reports it; a worked-out quarter must equal revenue less cost of revenue for that quarter, or it is a dash.
Operating income can be above gross profit when the company books other operating income between the two, shown on its own line.
Shares outstanding come from each filing's cover page, as of the date printed there.
Quarters are fiscal: Q2 FY27 is the second quarter of the company's fiscal 2027.

Income statement

Fiscal quarters (STAA's year ends in early January)

In thousands of dollars	Q3 FY23Sep 29, 2023	Q4 FY23Dec 29, 2023	Q1 FY24Mar 29, 2024	Q2 FY24Jun 28, 2024	Q3 FY24Sep 27, 2024	Q4 FY24Dec 27, 2024	Q1 FY25Mar 28, 2025	Q2 FY25Jun 27, 2025	Q3 FY25Sep 26, 2025	Q4 FY25Jan 2, 2026	Q1 FY26Apr 3, 2026	Q2 FY26Jul 3, 2026
Revenue	80,308	76,273*	77,356	99,005	88,590	48,950*	42,589	44,320	94,732	57,801*	93,522	93,535
Cost of goods and services sold	16,670	15,548*	16,321	20,593	20,103	17,302*	14,584	11,521	16,857	14,060*	24,663	23,808
Gross profit	63,638	60,725*	61,035	78,412	68,487	31,648*	28,005	32,799	77,875	43,741*	68,859	69,727
Research and development	11,470	10,866*	13,380	14,054	14,497	12,042*	13,663	10,263	9,209	9,244*	9,925	9,943
Selling, general and administrative	57,343	50,320*	63,316	66,514	62,805	59,558*	85,406	62,763	59,385	66,579*	60,880	59,626
General and administrative	19,266	16,858*	23,228	23,641	21,685	21,344*	24,458	20,969	20,763	19,593*	17,022	22,739
Operating income (loss)	6,295	10,405*	(2,281)	11,898	5,682	(27,910)*	(57,401)	(29,964)	18,490	(22,838)*	7,979	10,101
Other income (expense)	71	304*	330	63	139	283*	131	120	353	1,649*	443	394
Income tax expense (benefit)	1,929	5,983*	1,128	2,955	3,179	3,894*	(275)	(9,103)	9,906	(2,343)*	3,012	2,966
Net income (loss)	4,817	7,756*	(3,339)	7,379	9,980	(34,228)*	(54,211)	(16,812)	8,884	(18,309)*	5,206	8,058
Earnings per share, basic USD per share	0.10	0.16*	(0.07)	0.15	0.20	(0.69)*	(1.10)	(0.34)	0.18	(0.37)*	0.10	0.16
Earnings per share, diluted USD per share	0.10	0.16*	(0.07)	0.15	0.20	(0.71)*	(1.10)	(0.34)	0.18	(0.37)*	0.10	0.16
Weighted average shares, basic thousands of shares	48,613	48,814*	48,907	49,127	49,199	49,267*	49,344	49,520	49,633	49,760*	49,908	50,321
Weighted average shares, diluted thousands of shares	49,370	49,322*	48,907	49,811	49,731	48,051*	49,344	49,520	50,549	48,910*	50,900	51,501

Balance sheet

CSV

Fiscal quarters (STAA's year ends in early January)

In thousands of dollars	Q3 FY23Sep 29, 2023	Q4 FY23Dec 29, 2023	Q1 FY24Mar 29, 2024	Q2 FY24Jun 28, 2024	Q3 FY24Sep 27, 2024	Q4 FY24Dec 27, 2024	Q1 FY25Mar 28, 2025	Q2 FY25Jun 27, 2025	Q3 FY25Sep 26, 2025	Q4 FY25Jan 2, 2026	Q1 FY26Apr 3, 2026	Q2 FY26Jul 3, 2026
Cash and cash equivalents	127,432	183,038	224,024	192,776	164,003	144,159	173,114	167,131	176,155	153,150	131,864	148,579
Short-term investments	60,681	37,688	21,125	42,424	71,955	86,335	49,647	22,752	16,505	34,386	32,025	32,910
Accounts receivable	112,367	94,704	64,604	93,800	104,510	77,897	39,949	34,440	60,105	50,064	81,172	98,475
Total current assets	347,068	365,269	365,715	383,817	397,106	367,940	326,498	292,792	321,209	311,545	312,398	342,353
Property and equipment, net	62,886	66,835	72,337	77,500	81,580	84,889	74,957	74,417	72,605	73,323	71,738	69,930
Right-of-use asset	34,992	34,387	34,600	34,971	37,897	36,850	31,047	33,027	31,339	29,609	28,572	27,505
Goodwill	1,786	1,786	1,786	1,786	1,786	1,786	1,786	1,786	1,786	1,786	1,786	1,786
Total assets	471,521	488,692	492,535	512,745	537,590	509,524	457,364	437,781	456,362	451,678	451,118	475,205
Accounts payable	8,786	13,557	16,560	19,059	14,694	16,704	11,465	12,345	9,180	11,574	8,696	13,476
Total current liabilities	56,775	65,036	62,674	66,170	66,341	70,306	68,356	59,228	61,637	68,504	60,994	73,394
Lease liability, non-current	31,643	31,425	31,126	31,499	35,385	34,807	33,118	35,417	33,803	32,481	31,189	29,765
Total liabilities	92,926	102,738	99,747	103,642	109,468	112,189	107,392	101,208	102,582	107,494	98,752	109,807
Accumulated deficit	(55,124)	(47,368)	(50,707)	(43,328)	(33,348)	(67,576)	(121,787)	(138,599)	(129,715)	(148,024)	(142,818)	(134,760)
Total stockholders' equity	378,595	385,954	392,788	409,103	428,122	397,335	349,972	336,573	353,780	344,184	352,366	365,398
Total liabilities and equity	471,521	488,692	492,535	512,745	537,590	509,524	457,364	437,781	456,362	451,678	451,118	475,205
Common shares outstanding (cover page) thousands of shares	48,817	48,866	49,131	49,188	49,276	49,325	49,526	49,553	49,742	49,513	49,780	50,144

Cash flows

CSV

Fiscal quarters (STAA's year ends in early January)

In thousands of dollars	Q3 FY23Sep 29, 2023	Q4 FY23Dec 29, 2023	Q1 FY24Mar 29, 2024	Q2 FY24Jun 28, 2024	Q3 FY24Sep 27, 2024	Q4 FY24Dec 27, 2024	Q1 FY25Mar 28, 2025	Q2 FY25Jun 27, 2025	Q3 FY25Sep 26, 2025	Q4 FY25Jan 2, 2026	Q1 FY26Apr 3, 2026	Q2 FY26Jul 3, 2026
Net income (loss)	4,817	7,756*	(3,339)	7,379	9,980	(34,228)*	(54,211)	(16,812)	8,884	(18,309)*	5,206	8,058
Stock-based compensation	8,846*	182*	6,339	9,042*	7,160*	4,669*	6,015	7,802*	8,158*	8,613*	4,823	6,560*
Net cash from operating activities	(5,975)*	31,969*	21,680	(10,413)*	3,816*	642*	(5,734)	(27,249)*	2,667*	(3,914)*	(21,695)	19,690*
Purchases of property and equipment	9,185*	3,088*	5,202	6,236*	6,231*	5,725*	1,468	1,792*	883*	1,677*	443	494*
Net cash from investing activities	31,840*	22,402*	16,187	(20,668)*	(35,241)*	(19,495)*	35,351	25,120*	5,283*	(19,415)*	2,147	(1,366)*
Share repurchases	—	—	—	—	—	—	—	—	1,982*	0*	—	—
Net cash from financing activities	7,107*	367*	4,056	163*	1,615*	(110)*	(948)	(4,540)*	983*	(50)*	(1,693)	(1,502)*
Net change in cash	32,737*	55,606*	40,986	(31,248)*	(28,773)*	(19,844)*	28,955	(5,983)*	9,024*	(23,005)*	(21,286)	16,715*

Compare with peers

SIC 3851 and related industry codes, similar size. Each row is the latest quarter reported.

How peers are chosen

SIC 3851 and related industry codes with public float (or, where float is missing, quarterly revenue) between 0.2x and 5x the company's.
Each row is the latest quarter the company has reported, named in the Quarter column; when that filing is a 10-K, it is the fourth quarter, never the full year.
* marks a quarter worked out from the filing totals: for a 10-Q, the year-to-date total less the earlier one.

Company	Cash ($K)	Revenue, quarter ($K)	Operating cash flow, quarter ($K)	Shares outstanding	Quarter
Staar Surgical	148,579	93,535	19,690*	50.1M	Q2 FY26 10-QJul 3, 2026
National Vision Holdings	35,998	498,805	8,110*	79.1M	Q2 FY26 10-QJul 4, 2026
Bausch & Lomb	513,000	1,375,000	233,000*	357.5M	Q3 FY26 10-QSep 30, 2026
RxSight	66,717	24,546	45,216*	41.9M	Q3 FY26 10-QSep 30, 2026
Warby Parker	292,674	235,511	29,618*	not reported	Q2 FY26 10-QJun 30, 2026

Not investment advice. Not affiliated with the U.S. SEC.